Literature DB >> 21117172

Proteomic identification of CD44 interacting proteins.

Spyros S Skandalis1, Inna Kozlova, Ulla Engström, Ulf Hellman, Paraskevi Heldin.   

Abstract

CD44 is a cell surface receptor for hyaluronan which affects cell adhesion and migration, and has been implicated in chronic inflammation and in tumorigenesis. To elucidate the molecular mechanisms underlying its multiple functions, we used a peptide-based pull-down assay to identify proteins that interact with CD44. Nonphosphorylated or phosphorylated peptides from the intracellular CD44 C-terminus, were immobilized and used as baits. Interacting proteins were subjected to SDS-gel electrophoresis and were identified by MALDI-TOF mass spectrometry. Several interaction partners were identified, including proteins involved in cytoskeletal reorganization, transcription, endocytosis, and intracellular transport. An endogenous complex between CD44 and one of the interacting proteins, the actin binding protein IQGAP1, was demonstrated in several normal and transformed cell types.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21117172     DOI: 10.1002/iub.392

Source DB:  PubMed          Journal:  IUBMB Life        ISSN: 1521-6543            Impact factor:   3.885


  9 in total

1.  GL-9 peptide regulates gene expression of CD44 cancer marker and pro-inflammatory cytokine TNF-α in human lung epithelial adenocarcinoma cell line (A549).

Authors:  Kosar Hooshmand; Ahmad Asoodeh; Fatemeh Behnam-Rassouli
Journal:  Mol Cell Biochem       Date:  2016-10-04       Impact factor: 3.396

Review 2.  IQGAP1: a regulator of intracellular spacetime relativity.

Authors:  Subramaniam Malarkannan; Aradhana Awasthi; Kamalakannan Rajasekaran; Pawan Kumar; Kristina M Schuldt; Allison Bartoszek; Niranjan Manoharan; Nicholas K Goldner; Colleen M Umhoefer; Monica S Thakar
Journal:  J Immunol       Date:  2012-03-01       Impact factor: 5.422

3.  Platelet-derived growth factor β-receptor, transforming growth factor β type I receptor, and CD44 protein modulate each other's signaling and stability.

Authors:  Helena Porsch; Merima Mehić; Berit Olofsson; Paraskevi Heldin; Carl-Henrik Heldin
Journal:  J Biol Chem       Date:  2014-05-23       Impact factor: 5.157

Review 4.  IQGAP1: insights into the function of a molecular puppeteer.

Authors:  Alex M Abel; Kristina M Schuldt; Kamalakannan Rajasekaran; David Hwang; Matthew J Riese; Sridhar Rao; Monica S Thakar; Subramaniam Malarkannan
Journal:  Mol Immunol       Date:  2015-02-28       Impact factor: 4.407

5.  Interleukin-1β-induced Reduction of CD44 Ser-325 Phosphorylation in Human Epidermal Keratinocytes Promotes CD44 Homomeric Complexes, Binding to Ezrin, and Extended, Monocyte-adhesive Hyaluronan Coats.

Authors:  Tiina Jokela; Sanna Oikari; Piia Takabe; Kirsi Rilla; Riikka Kärnä; Markku Tammi; Raija Tammi
Journal:  J Biol Chem       Date:  2015-03-25       Impact factor: 5.157

Review 6.  Serglycin: at the crossroad of inflammation and malignancy.

Authors:  Angeliki Korpetinou; Spyros S Skandalis; Vassiliki T Labropoulou; Gianna Smirlaki; Argyrios Noulas; Nikos K Karamanos; Achilleas D Theocharis
Journal:  Front Oncol       Date:  2014-01-13       Impact factor: 6.244

7.  Hyaluronic Acid in Vascular and Immune Homeostasis during Normal Pregnancy and Preeclampsia.

Authors:  M M Ziganshina; S V Pavlovich; N V Bovin; G T Sukhikh
Journal:  Acta Naturae       Date:  2016 Jul-Sep       Impact factor: 1.845

8.  Dynamic actin-mediated nano-scale clustering of CD44 regulates its meso-scale organization at the plasma membrane.

Authors:  Parijat Sil; Nicolas Mateos; Sangeeta Nath; Sonja Buschow; Carlo Manzo; Kenichi G N Suzuki; Takahiro Fujiwara; Akihiro Kusumi; Maria F Garcia-Parajo; Satyajit Mayor
Journal:  Mol Biol Cell       Date:  2019-10-02       Impact factor: 4.138

9.  TRAF4/6 Is Needed for CD44 Cleavage and Migration via RAC1 Activation.

Authors:  Constantinos Kolliopoulos; Athanasios Chatzopoulos; Spyros S Skandalis; Carl-Henrik Heldin; Paraskevi Heldin
Journal:  Cancers (Basel)       Date:  2021-03-01       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.